These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7625788)

  • 1. Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution models.
    Keil S; Wiedemann B
    Antimicrob Agents Chemother; 1995 May; 39(5):1054-8. PubMed ID: 7625788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model.
    Mohamed AF; Kristoffersson AN; Karvanen M; Nielsen EI; Cars O; Friberg LE
    J Antimicrob Chemother; 2016 May; 71(5):1279-90. PubMed ID: 26850719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacodynamics of meropenem using an in-vitro model to simulate once, twice and three times daily dosing in humans.
    Bowker KE; Holt HA; Lewis RJ; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1998 Oct; 42(4):461-7. PubMed ID: 9818744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical modelling response of Pseudomonas aeruginosa to meropenem.
    Tam VH; Schilling AN; Poole K; Nikolaou M
    J Antimicrob Chemother; 2007 Dec; 60(6):1302-9. PubMed ID: 17913722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro pharmacodynamics of imipenem and meropenem against Pseudomonas aeruginosa.
    White R; Friedrich L; Burgess D; Warkentin D; Bosso J
    Antimicrob Agents Chemother; 1996 Apr; 40(4):904-8. PubMed ID: 8849249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms.
    Haagensen JA; Verotta D; Huang L; Spormann A; Yang K
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4074-81. PubMed ID: 25918138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model.
    DeRyke CA; Banevicius MA; Fan HW; Nicolau DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1481-6. PubMed ID: 17283197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling time-kill studies to discern the pharmacodynamics of meropenem.
    Tam VH; Schilling AN; Nikolaou M
    J Antimicrob Chemother; 2005 May; 55(5):699-706. PubMed ID: 15772138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Moczygemba LR; Frei CR; Burgess DS
    Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antibacterial activity and beta-lactamase stability of meropenem].
    Poiată A; Tuchiluş C; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):589-94. PubMed ID: 14756067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa.
    Tam VH; Schilling AN; Neshat S; Poole K; Melnick DA; Coyle EA
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4920-7. PubMed ID: 16304153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro study of several pharmacodynamic effects of meropenem.
    Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
    Scand J Infect Dis; 1995; 27(5):469-74. PubMed ID: 8588137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity, post antibiotic effect and modified controlled effective regrowth time of meropenem at high concentrations.
    Bowker KE; Holt HA; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1996 Dec; 38(6):1055-60. PubMed ID: 9023653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic profiling of imipenem, meropenem and ertapenem against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. from Brazil.
    Kiffer CR; Kuti JL; Eagye KJ; Mendes C; Nicolau DP
    Int J Antimicrob Agents; 2006 Oct; 28(4):340-4. PubMed ID: 16930951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases.
    Sanders CC; Sanders WE; Thomson KS; Iaconis JP
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():187-96. PubMed ID: 2808207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
    Yang Y; Bhachech N; Bush K
    J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vivo and in-vitro study of the postantibiotic effect of meropenem.
    Martín Caminero MM; Fuentes Martinez F; Izquierdo Izquierdo J; Gómez-Lus Centelles ML; Prieto Prieto J
    J Antimicrob Chemother; 1993 Dec; 32(6):917-8. PubMed ID: 8144441
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model.
    Keil S; Wiedemann B
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1215-9. PubMed ID: 9174173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pharmacodynamic target attainment between healthy subjects and patients for ceftazidime and meropenem.
    Kuti JL; Horowitz S; Nightingale CH; Nicolau DP
    Pharmacotherapy; 2005 Jul; 25(7):935-41. PubMed ID: 16006272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the pharmacodynamic profile of intravenous antibiotics against prevalent Gram-negative organisms collected in Colombia.
    Villegas MV; Briceno DF; Ruiz SJ; Furtado GH; Nicolau DP
    Braz J Infect Dis; 2011; 15(5):413-9. PubMed ID: 22230846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.